Delineating the autistic phenotype in children with neurofibromatosis type 1.

MLA

Chisholm A.K., et al. Delineating the Autistic Phenotype in Children with Neurofibromatosis Type 1. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1305131700&authtype=sso&custid=ns315887.

APA

Chisholm A.K., Haebich K.M., Pride N.A., Walsh K.S., Lami F., Ure A., Maloof T., Brignell A., Rouel M., Granader Y., Maier A., Barton B., Darke H., Dabscheck G., Anderson V.A., Williams K., North K.N., & Payne J.M. (2022). Delineating the autistic phenotype in children with neurofibromatosis type 1.

Chicago

Chisholm A.K., Haebich K.M., Pride N.A., Walsh K.S., Lami F., Ure A., Maloof T., et al. 2022. “Delineating the Autistic Phenotype in Children with Neurofibromatosis Type 1.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1305131700&authtype=sso&custid=ns315887.